What the FDA labels say about taking them together
Ergotamine and nevirapine
Nevirapine's FDA label of July 15, 2026 names ergotamine in its drug interactions section; the ergotamine label PlainMeds reads does not name nevirapine. The nevirapine label: “Ergot Alkaloids: Ergotamine Plasma concentrations may be decreased.”
Check it at the source: the ergotamine FDA label on DailyMed (effective February 25, 2025, Pangea Pharmaceuticals LLC); the nevirapine FDA label on DailyMed (effective July 15, 2026, Mylan Pharmaceuticals Inc.).
What does the ergotamine label say about nevirapine?
Ergotamine's label (effective February 25, 2025) does not name nevirapine in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Ergomar Sublingual), Pangea Pharmaceuticals LLC, effective February 25, 2025 (SPL set a9582fdb-7ddd-4f69-aa7a-66247cdb8c92), via openFDA; the full label on DailyMed
What does the nevirapine label say about ergotamine?
Nevirapine label, drug interactionsErgot Alkaloids: Ergotamine Plasma concentrations may be decreased.
Source: FDA drug label (Nevirapine), Mylan Pharmaceuticals Inc., effective July 15, 2026 (SPL set c6e93829-7024-48f6-8023-da6ff27dfc0a), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Ergotamine | Nevirapine | |
|---|---|---|
| Labeled for | n/a | HIV |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | $43.46 per tablet 2 mg tablet sublingual | $0.147 per tablet 200 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once